Khiroya Reena, Macaluso Claudio, Montero Maria A, Wells Athol U, Chua Felix, Kokosi Maria, Maher Toby M, Devaraj Anand, Rice Alexandra, Renzoni Elisabetta A, Nicholson Andrew G
Departments of *Histopathology §Radiology, Royal Brompton and Harefield NHS Foundation Trust †Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College ‡National Heart and Lung Institute, Imperial College, London, UK.
Am J Surg Pathol. 2017 Dec;41(12):1683-1689. doi: 10.1097/PAS.0000000000000928.
Pleuroparenchymal fibroelastosis (PPFE) is now a defined clinicopathologic entity in the updated 2013 ATS/ERS classification of idiopathic interstitial pneumonias (IIPs), which has led to a significant increase in cases being diagnosed at our institution. We have therefore reviewed 43 PPFE cases (58 biopsies in total) to assess whether any clinical or histopathologic features provide prognostic information. A semiquantatitive grading system was used to assess extent of fibroblastic foci, intra-alveolar fibroelastosis, visceral pleural fibrosis, chronic inflammation in areas of fibrosis, vascular fibrointimal thickening, and presence of granulomas. Other patterns of interstitial lung disease were also noted, if present. All biopsies showed intra-alveolar fibroelastosis, fibroblastic foci at the leading edge of fibrosis and chronic inflammation within areas of fibrosis, 91% showed vascular fibrointimal thickening of vessels, 73% showed pleural fibrosis, and 35% showed granulomas. Ten cases showed a coexistent IIP (5 showed usual interstitial pneumonia, 5 showed features of hypersensitivity pneumonitis). There was no significant correlation with mortality and severity of histologic parameters, other than a significant decrease in mortality in PPFE with coexistent granulomas, after adjusting for age and gender (hazard ratio, 0.27; P=0.049). Male gender was also associated with an increased risk of mortality, after adjusting for age (hazard ratio, 4.8; P=0.045). PPFE is more common than previously thought, not infrequently showing coexistent pathology, specifically usual interstitial pneumonia and granulomatous lung disease, our data suggesting the latter may have prognostic significance.
胸膜实质纤维弹性组织增生症(PPFE)现已成为2013年更新的美国胸科学会/欧洲呼吸学会特发性间质性肺炎(IIP)分类中的一个明确的临床病理实体,这使得我们机构诊断的病例显著增加。因此,我们回顾了43例PPFE病例(共58次活检),以评估是否有任何临床或组织病理学特征可提供预后信息。采用半定量分级系统评估成纤维细胞灶的范围、肺泡内纤维弹性组织增生、脏层胸膜纤维化、纤维化区域的慢性炎症、血管纤维内膜增厚以及肉芽肿的存在情况。如果存在其他间质性肺疾病模式,也会予以记录。所有活检均显示肺泡内纤维弹性组织增生、纤维化前沿的成纤维细胞灶以及纤维化区域内的慢性炎症,91%显示血管纤维内膜增厚,73%显示胸膜纤维化,35%显示肉芽肿。10例病例同时存在IIP(5例显示普通型间质性肺炎,5例显示过敏性肺炎特征)。除了在调整年龄和性别后,PPFE合并肉芽肿患者的死亡率显著降低(风险比,0.27;P = 0.049)外,组织学参数的严重程度与死亡率无显著相关性。在调整年龄后,男性性别也与死亡风险增加相关(风险比,4.8;P = 0.045)。PPFE比之前认为的更为常见,常伴有其他病理情况,特别是普通型间质性肺炎和肉芽肿性肺病,我们的数据表明后者可能具有预后意义。